| Online medical marketing intelligence firm MedPanel, whose clients include nine of the world's 10 largest pharmaceutical companies, has released Profiles in Pancreatic Cancer, the third in its 2005-2006 Profiles in Oncology series. The series aims to help companies evaluate the clinical and commercial markets in a certain therapeutic category. The newest study offers analysis of the treatment of the advanced- and metastatic-patient population. The studies, which are released quarterly, include best practices, key outcome measures, unmet medical needs, and the future direction of treatment. Profiles in Oncology clients include Eli Lilly, Novartis, Roche, and GlaxoSmithKline, according to the Web site. Go to MedPanel.com to learn more. |
0 comments:
Post a Comment